In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $111.77, changing hands for $112.26/share. When a stock reaches the ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD ...

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for virology, oncology and other therapeutic areas in the United States, Europe, and ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Naturally, the streaming service has stayed close-clipped on specific plot developments, but a recent teaser trailer has similarly eschewed subtlety (with a voiceover from June) while promising to ...

Clinical data presented at SITC 2024 supports further development of COM701, potential first-in-class anti-PVRIG antibody On track to initiate a randomized adaptive ...

The Handmaid’s Tale Moira (Samira Wiley) and June (Elisabeth Moss) share a bond that transcends dystopia, oppression, and distance. From their carefree pre-Gilead days to their harrowing separation, ...

AUSTIN – Grime clings to the grayish limestone of the University of Texas Tower. Metal panels are rusted orange under the hundreds of windows. The clock is tarnished brown. That’s what almost 90 years ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90 ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Gilead Sciences Inc. closed 8.11% short of its 52-week high of $119.96, which the company achieved on March 10th.

Gilead Sciences recently experienced a significant price movement, rising 24% in the last quarter. This upward trajectory coincides with positive developments in its HIV treatment portfolio ...